William Amsbaugh
Hoofd Techniek/Wetenschap/O&O bij Cure Ventures Management LP
Actieve functies van William Amsbaugh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Hoofd Techniek/Wetenschap/O&O | 01-07-2021 | - |
| Private Equity Investor | 01-07-2021 | - |
Loopbaan van William Amsbaugh
Eerdere bekende functies van William Amsbaugh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Cogitas Holdings, Inc.
 Cogitas Holdings, Inc. Information Technology ServicesTechnology Services Cogitas Holdings, Inc. provides healthcare IT services. The American company was founded by Stephen Ellis. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | 30-06-2021 |
| CONSTELLATION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-01-2012 | 01-07-2014 |
Opleiding van William Amsbaugh
| Western New England University | Undergraduate Degree |
| Boston University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sectoraal
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts. | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Cogitas Holdings, Inc.
Cogitas Holdings, Inc. Information Technology ServicesTechnology Services Cogitas Holdings, Inc. provides healthcare IT services. The American company was founded by Stephen Ellis. | Technology Services |
- Beurs
- Insiders
- William Amsbaugh
- Ervaring
